摘要
英国、加拿大、美国和德国的医疗保险制度不尽相同,但均通过制度来保障医疗保险的循证决策,并由专业的组织机构提供循证决策支持信息。各国的实践经验表明,新技术是循证决策支持的重点,明确的方法学指南指导证据分析,循证决策支持信息整合了研究证据、专家观点以及患者/用户的价值观。严谨的循证决策依据与推荐意见、决策支持信息的公开透明保障了决策的科学性和公正性。建议我国完善医疗保险的循证决策制度,决策支持机构公开透明提供经评价的科学证据,决策者切实将高质量的证据作为决策依据。
Although insurance systems are not the same in United Kingdom, Canada, United States and Germany, evidence-based reimbursement decision-making is guaranteed by national policies, and the decision is supported by specialized academic organizations and institutions. According to the experiences, new health technology became the priority for evidence-based decision-making. The evidence is analyzed in consistence with the explicit methodology guideline. Evidence, experts＇ views and patient/consumer values are integrated in the evidence-based decision support information. Rigid evidence and reimbursement recommendation, and the open and transparent evidence are ensured to guarantee the scientific and equitable nature of the decision-making process. Consequently, it is proposed that the evidence-based reimbursement system in our country should also be improved. Institutions should provide assessed evidence in an open and transparent manner, and decision-makers should utilize high quality evidence during the decision-making.
出处
《医学与哲学（A）》
北大核心
2016年第4期70-72,共3页
Medicine & Philosophy:Humanistic & Social Medicine Edition
基金
2014年度教育部人文社会科学研究一般项目
项目编号:14YJCZH035
2015年度美国中华医学基金会"中国卫生技术评估联合项目开放基金"
项目编号:CMB:13-153
关键词
医疗保险
卫生技术
循证决策
medical insurance
health technology
evidence-based decision-making
